NL-OMON38980撤回不适用
Re-evaluation of anti-TNF use in a cohort of IBD patients in a non-academic hospital. - stop anti TNF.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18 years or older
- •mentally compentent
- •diagnose of IBD
- •signed informed consent
- •well known history
排除标准
- •pregnant women
- •existing treatment with MTX
- •history of fistels
- •second indication for anti TNF, such as Bechterew
- •serious co-morbidiy
- •unable to understand or write Dutch
- •serious transfusionreaction on infliximab or Humira in the past
研究者
相似试验
Enrolling By Invitation
4 期
De-escalation of Anti-TNF Therapy in Inflammatory Bowel DiseaseInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseNCT04646187University Medical Center Groningen148
已完成
不适用
Long-term Outcome of TNF Alpha Therapy in IBDIBDNCT04575701Medical University of Graz538
已完成
不适用
Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)Inflammatory Bowel DiseasesNCT01971970Erasmus Medical Center45
终止
不适用
Evaluate if Response to Infliximab or Adalimumab May be Regained With an ImmunomodulatorUlcerative ColitisCrohn's DiseaseInflammatory Bowel DiseaseNCT02413047Indiana University3
进行中（未招募）
1 期
Anti-TNF discontinuation in patients with inflammatory bowel diseaseInflammatory bowel diseaseMedDRA version: 19.0Level: LLTClassification code 10021973Term: Inflammatory bowel disease NOSSystem Organ Class: 100000004856EUCTR2015-001410-10-ESFundación de Investigación Biomédica Hospital Universitario de la Princesa300